PE20061434A1 - MULTIVALENT HPV VACCINE - Google Patents
MULTIVALENT HPV VACCINEInfo
- Publication number
- PE20061434A1 PE20061434A1 PE2006000425A PE2006000425A PE20061434A1 PE 20061434 A1 PE20061434 A1 PE 20061434A1 PE 2006000425 A PE2006000425 A PE 2006000425A PE 2006000425 A PE2006000425 A PE 2006000425A PE 20061434 A1 PE20061434 A1 PE 20061434A1
- Authority
- PE
- Peru
- Prior art keywords
- hpv
- vaccine
- psv
- proteins
- refers
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
SE REFIERE A UNA VACUNA MULTIVALENTE DE PAPILOMAVIRUS HUMANO (VPH) QUE COMPRENDE: A) PROTEINAS L1 O FRAGMENTOS INMUNOGENICOS DE LAS MISMAS DE VPH-16 Y VPH 18 Y AL MENOS OTRO TIPO ONCOGENICO DE VPH TAL COMO VPH-33, VPH-58 O VPH-59; SIENDO OMITIDOS LOS TIPOS VPH-31, VPH-45 Y VPH-52. EN DICHA VACUNA LA PROTEINA L1 DE VPH O FRAGMENTOS DE LA MISMA SE ENCUENTRA EN FORMA DE UN CAPSOMERO O PARTICULA SEMEJANTE AL VIRUS (PSV), Y AL MENOS UNA DE LAS PROTEINAS L1 ES UNA L1 TRUNCADA DONDE LA CANTIDAD DE VACUNA VARIA CON EL NUMERO DE TIPOS DE PSV EN UNA CANTIDAD COMPRENDIDA ENTRE 1 A 100 UG DE CADA PSV Y B) UN ADYUVANTE TALES COMO HIDROXIDO DE ALUMINIO, UNA EMULSION DE ACEITE EN AGUA. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE FABRICACION. DICHA VACUNA PROPORCIONA PROTECCION CRUZADA CONTRA LA INFECCION CAUSADA POR EL TIPO DE VPH OMITIDOREFERS TO A MULTIVALENT VACCINE OF HUMAN PAPILLOMAVIRUS (HPV) THAT INCLUDES: A) L1 PROTEINS OR IMMUNOGENIC FRAGMENTS OF THE SAME OF HPV-16 AND HPV 18 AND AT LEAST ANOTHER ONCOGENIC TYPE OF HPV, SUCH AS HPV-33 HPV-59; THE HPV-31, HPV-45 AND HPV-52 TYPES ARE OMITTED. IN SUCH VACCINE, HPV L1 PROTEIN OR FRAGMENTS OF IT IS IN THE FORM OF A CAPSOMER OR VIRUS-LIKE PARTICLE (PSV), AND AT LEAST ONE OF THE L1 PROTEINS IS A TRUNCATED L1 WHERE THE NUMBER OF VACCINE VARIES OF TYPES OF PSV IN A QUANTITY INCLUDED BETWEEN 1 TO 100 UG OF EACH PSV AND B) AN ADJUVANT SUCH AS ALUMINUM HYDROXIDE, AN EMULSION OF OIL IN WATER. IT ALSO REFERS TO A MANUFACTURING PROCEDURE. SUCH VACCINE PROVIDES CROSS PROTECTION AGAINST INFECTION CAUSED BY THE MISSED TYPE OF HPV
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
PCT/EP2005/006461 WO2005123125A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
US11/367,601 US7858098B2 (en) | 2002-12-20 | 2005-12-16 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20061434A1 true PE20061434A1 (en) | 2007-01-26 |
Family
ID=42334365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000425A PE20061434A1 (en) | 2005-04-26 | 2006-04-24 | MULTIVALENT HPV VACCINE |
Country Status (3)
Country | Link |
---|---|
IL (1) | IL186591A0 (en) |
MA (1) | MA29679B1 (en) |
PE (1) | PE20061434A1 (en) |
-
2006
- 2006-04-24 PE PE2006000425A patent/PE20061434A1/en not_active Application Discontinuation
-
2007
- 2007-10-11 IL IL186591A patent/IL186591A0/en unknown
- 2007-10-29 MA MA30331A patent/MA29679B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL186591A0 (en) | 2008-01-20 |
MA29679B1 (en) | 2008-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2018010I1 (en) | HPV 31 L1 protein | |
ECSP055869A (en) | HPV-16 AND -18 L1 VLP VACCINE | |
EA201190327A1 (en) | NEW CONSTRUCTIONS OF HUMAN PAPILLOMA VIRUS PROTECTION (HPV) AND THEIR APPLICATION IN THE PREVENTION OF DISEASE CAUSED BY HPV | |
TW200519203A (en) | Optimized expression of HPV 58 L1 in yeast | |
AR077396A2 (en) | OPTIMIZED EXPRESSION OF THE L1 CAPSIDE PROTEIN OF THE VPH45 HUMAN PAPILOMA VIRUS IN LEAVES | |
ES2263406T1 (en) | PRODUCTION OF CAPSIDA L1 PROTEIN AND HUMAN PAPILOMAVIRUS VIRUS TYPE VIRUS PARTICLES HBV-11. | |
WO2007121894A3 (en) | Hpv-18-based papillomavirus vaccine | |
MY139031A (en) | Vaccine composition comprising virus-like particles of human papillomavirus | |
EP2708549A3 (en) | Improved vaccines and methods for using the same | |
DK1968632T3 (en) | Improved influenza vaccine | |
WO2007121895A3 (en) | Hpv-16-based papillomavirus vaccine | |
MX2020011299A (en) | Improved vaccines for human papilloma virus and methods for using the same. | |
RU2017139870A (en) | NEW NPR-B AGONISTS | |
JP2006512413A5 (en) | ||
BR112018011310A2 (en) | A mutant of human papillomavirus type 58 L1 protein | |
JP2015504897A5 (en) | ||
DE602005019238D1 (en) | OTEINEN | |
AR054259A1 (en) | VACCINE AGAINST HUMAN PAPILOMA VIRUS (HPV) | |
BR112018011331A2 (en) | human papillomavirus l1 protein mutant type 11 | |
JP2008539184A5 (en) | ||
PE20230349A1 (en) | VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS OF USING THESE | |
PE20061434A1 (en) | MULTIVALENT HPV VACCINE | |
CO5580837A2 (en) | DNA VACCINE CODING AT LEAST TWO NON-STRUCTURAL EARLY PROTEINS OF PAPILOMAVIRUS | |
PE20061320A1 (en) | VACCINE AGAINST HUMAN PAPILLOMA VIRUS (HPV) | |
JP2008539182A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |